BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15782116)

  • 21. Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
    Chacko AD; McDade SS; Chanduloy S; Church SW; Kennedy R; Price J; Hall PA; Russell SE
    Cell Oncol (Dordr); 2012 Apr; 35(2):85-93. PubMed ID: 22278362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of archival formalin-fixed paraffin-embedded mouse liver samples for use with the Agilent gene expression microarray platform.
    Jackson AF; Williams A; Moffat I; Phillips SL; Recio L; Waters MD; Lambert IB; Yauk CL
    J Pharmacol Toxicol Methods; 2013; 68(2):260-268. PubMed ID: 23458726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents.
    Amir S; Mabjeesh NJ
    Cancer Biol Ther; 2007 Dec; 6(12):1926-31. PubMed ID: 18075300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling.
    Sudo K; Ito H; Iwamoto I; Morishita R; Asano T; Nagata K
    Hum Mutat; 2007 Oct; 28(10):1005-13. PubMed ID: 17546647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis.
    Peterson EA; Stanbery L; Li C; Kocak H; Makarova O; Petty EM
    Genes Chromosomes Cancer; 2011 Nov; 50(11):940-9. PubMed ID: 21910160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SEPT9 mutations and a conserved 17q25 sequence in sporadic and hereditary brachial plexus neuropathy.
    Klein CJ; Wu Y; Cunningham JM; Windebank AJ; Dyck PJ; Friedenberg SM; Klein DM; Dyck PJ
    Arch Neurol; 2009 Feb; 66(2):238-43. PubMed ID: 19204161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients.
    Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Oncol Rep; 2016 Oct; 36(4):2225-35. PubMed ID: 27499429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational control of SEPT9 isoforms is perturbed in disease.
    McDade SS; Hall PA; Russell SE
    Hum Mol Genet; 2007 Apr; 16(7):742-52. PubMed ID: 17468182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.
    deVos T; Tetzner R; Model F; Weiss G; Schuster M; Distler J; Steiger KV; Grützmann R; Pilarsky C; Habermann JK; Fleshner PR; Oubre BM; Day R; Sledziewski AZ; Lofton-Day C
    Clin Chem; 2009 Jul; 55(7):1337-46. PubMed ID: 19406918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High SEPT9_i1 protein expression is associated with high-grade prostate cancers.
    Gilad R; Meir K; Stein I; German L; Pikarsky E; Mabjeesh NJ
    PLoS One; 2015; 10(4):e0124251. PubMed ID: 25898316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in SEPT9 cause hereditary neuralgic amyotrophy.
    Kuhlenbäumer G; Hannibal MC; Nelis E; Schirmacher A; Verpoorten N; Meuleman J; Watts GD; De Vriendt E; Young P; Stögbauer F; Halfter H; Irobi J; Goossens D; Del-Favero J; Betz BG; Hor H; Kurlemann G; Bird TD; Airaksinen E; Mononen T; Serradell AP; Prats JM; Van Broeckhoven C; De Jonghe P; Timmerman V; Ringelstein EB; Chance PF
    Nat Genet; 2005 Oct; 37(10):1044-6. PubMed ID: 16186812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression.
    Kasper G; Vogel A; Klaman I; Gröne J; Petersen I; Weber B; Castaños-Vélez E; Staub E; Mennerich D
    Cancer Lett; 2005 Jun; 224(1):93-103. PubMed ID: 15911104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma.
    Haque T; Faury D; Albrecht S; Lopez-Aguilar E; Hauser P; Garami M; Hanzély Z; Bognár L; Del Maestro RF; Atkinson J; Nantel A; Jabado N
    Clin Cancer Res; 2007 Nov; 13(21):6284-92. PubMed ID: 17975139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the QuantiGene 2.0 Assay and Real-Time RT-PCR in the Detection of p53 Isoform mRNA Expression in Formalin-Fixed Paraffin-Embedded Tissues- A Preliminary Study.
    Morten BC; Scott RJ; Avery-Kiejda KA
    PLoS One; 2016; 11(11):e0165930. PubMed ID: 27832134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry.
    Hecht M; Rösler R; Wiese S; Johnsson N; Gronemeyer T
    G3 (Bethesda); 2019 Jun; 9(6):1869-1880. PubMed ID: 30975701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours.
    Jones AM; Mitter R; Poulsom R; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
    J Pathol; 2008 Dec; 216(4):408-17. PubMed ID: 18937276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
    Heringlake S; Hofdmann M; Fiebeler A; Manns MP; Schmiegel W; Tannapfel A
    J Hepatol; 2010 Feb; 52(2):220-7. PubMed ID: 20036025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissue.
    Green TM; de Stricker K; Møller MB
    Diagn Mol Pathol; 2009 Dec; 18(4):243-9. PubMed ID: 19861891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.